Zero-covid advocacy during the COVID-19 pandemic: a case study of views on Twitter/X.
Kasper P KeppKevin Louis BardoshTijl De BieLouise EmilssonJustin GreavesTea LallukkaTaulant MukaJ Christian RangelNiclas SandströmMichaéla C SchippersJonas Schmidt-ChanasitTracy VaillancourtPublished in: Monash bioethics review (2024)
During the COVID-19 pandemic, many advocacy groups and individuals criticized governments on social media for doing either too much or too little to mitigate the pandemic. In this article, we review advocacy for COVID-19 elimination or "zero-covid" on the social media platform X (Twitter). We present a thematic analysis of tweets by 20 influential co-signatories of the World Health Network letter on ten themes, covering six topics of science and mitigation (zero-covid, epidemiological data on variants, long-term post-acute sequelae (Long COVID), vaccines, schools and children, views on monkeypox/Mpox) and four advocacy methods (personal advice and promoting remedies, use of anecdotes, criticism of other scientists, and of authorities). The advocacy, although timely and informative, often appealed to emotions and values using anecdotes and strong criticism of authorities and other scientists. Many tweets received hundreds or thousands of likes. Risks were emphasized about children's vulnerability, Long COVID, variant severity, and Mpox, and via comparisons with human immunodeficiency viruses (HIV). Far-reaching policies and promotion of remedies were advocated without systematic evidence review, or sometimes, core field expertise. We identified potential conflicts of interest connected to private companies. Our study documents a need for public health debates to be less polarizing and judgmental, and more factual. In order to protect public trust in science during a crisis, we suggest the development of mechanisms to ensure ethical guidelines for engagement in "science-based" advocacy, and consideration of cost-benefit analysis of recommendations for public health decision-making.
Keyphrases
- social media
- public health
- coronavirus disease
- sars cov
- health information
- respiratory syndrome coronavirus
- healthcare
- global health
- decision making
- climate change
- mental health
- endothelial cells
- clinical practice
- hiv positive
- human immunodeficiency virus
- hiv testing
- hiv aids
- machine learning
- dna methylation
- intensive care unit
- antiretroviral therapy
- respiratory failure
- high throughput
- south africa
- single cell
- adverse drug